- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06531980
Effectiveness of a Digital Application for Adolescents With Mild to Moderate Anxiety
Effektiviteten av en Digital Mestringsapp for Ungdommer Med Mild Til Moderat Angst
The goal of this randomized controlled trial is to investigate the effectiveness of a new therapist-guided rule based intervention in Bergen Municipality, Child and Family help center.
Do they have a decrease in anxiety symptoms following the intervention? Do they have an increase in functional level following the intervention?
Researchers will compare the therapist-guided rule based intervention with treatment as usual for adolescents with mild to moderate anxiety.
Participants will use the intervention, which is based on CBT, for 8 weeks.
Study Overview
Status
Intervention / Treatment
Detailed Description
Modi is a mobile application and consists of a training program for adolescents with anxiety problems. Anxiety is one of the most common mental disorders. The anxiety symptoms usually have an age of onset in adolescence. For many, these anxiety symptoms persist into adulthood, and lead to reduced quality of life and functional impairment. The goal is to prevent anxiety disorders, comorbid disorders and loss of function as a result of the anxiety symptoms.
This study wants to investigate the effectiveness of a digital intervention in a randomized controlled trial. The study will recruit N = 128 young people aged 13-16 who will be randomized to either a therapist-guided, rule-based chatbot intervention or treatment as usual in the Child and Family Help Center in Bergen Municipality. The study will examine the clinical effects of the new intervention compared to treatment as usual
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tine Nordgreen, PhD
- Phone Number: +4790094913
- Email: tine.nordgreen@helse-bergen.no
Study Contact Backup
- Name: Smiti Kahlon, PhD
- Phone Number: +4798866640
- Email: smiti.kahlon@helse-bergen.no
Study Locations
-
-
Vestland
-
Bergen, Vestland, Norway, 5009
- Recruiting
- Research centre for digital mental health services, Haukeland University Hospital
-
Contact:
- Tine Nordgreen, PhD
- Email: tine.nordgreen@helse-bergen.no
-
Contact:
- Smiti Kahlon, PhD
- Phone Number: 004798866640
- Email: smiti.kahlon@helse-bergen.no
-
Principal Investigator:
- Smiti Kahlon, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ages 13-16
- Resides in Bergen
- Completed RCADS-25
- Reports "yes" to both questions:
- Do you have anxiety symptoms? Do you often feel stressed, scared, worried, or feel it in your body (e.g., stomach pain, heart palpitations, breathing problems, sweating, dizziness)?
- Do anxiety symptoms prevent you from doing things you want or need to do (e.g., meeting new people, giving presentations at school, going to sleepovers, going to the shopping center)? Or do you spend so much time worrying that it affects your daily life? Can read Norwegian
Exclusion Criteria:
- Currently receiving other psychological treatment
- Immediate need for other psychological treatment, such as severe depression, suicide risk, OCD, psychosis/substance abuse issues, autism spectrum disorder
- Anxiety is largely related to bullying
- Extensive school absence of more than 50% in the last three months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Modi-application
8-weeks interventions provided by the mobile application Modi.
Therapist-guided intervention
|
The Modi course, an eight-week mobile application intervention for adolescents with anxiety symptoms, is based on cognitive therapy.
Guided by a rule-based chatbot named "Anna," users navigate through predefined options and responses, learning about anxiety and recording their challenges.
The app includes animated videos, illustrations, and audio files to enhance engagement.
Modi consists of six chapters, with a focus on psychoeducation, the cognitive triangle, and exposure exercises.
Participants receive guidance from two Modi therapists who provide weekly support via messages and scheduled phone calls, ensuring personalized assistance and addressing any issues throughout the course.
|
|
Active Comparator: Treatment as usual
The group will receive treatment as usual.
|
Participants receive usual treatment at their local Child and Family Services.
This treatment, known as Treatment as Usual (TAU), is not standardized but reflects the care they would receive in regular practice.
It aligns with national clinical guidelines and includes individual therapy, parental counseling, and assessments.
Typically, the treatment is provided by a therapist trained in cognitive behavioral therapy (CBT) or a psychologist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Revised Child Anxiety and Depression Scale - 25 - Self-report
Time Frame: assessing change from screening, pre, week 2, week 4, week 6, and immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
anxiety and depressive symptoms, higher score indicates worse outcomes
|
assessing change from screening, pre, week 2, week 4, week 6, and immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
|
Revised Child Anxiety and Depression Scale - 25 - Parent-report
Time Frame: assessing change from screening, pre, week 2, week 4, week 6, and immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
anxiety and depressive symptoms, higher score indicates worse outcomes
|
assessing change from screening, pre, week 2, week 4, week 6, and immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Strengths and Difficulties Questionnaire - Youth version
Time Frame: assessing change from screening, pre, week 4, immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
The scale measure adolescent's general mental health, with a higher score indicating worse symptoms.
The study intends to use all three components of the measurement, including 1) the basis of SDQ, which includes 25 items on psychological attributes, 2) impact supplement, measuring functional level.
The follow-up version also includes two additional follow-up questions
|
assessing change from screening, pre, week 4, immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
|
Strengths and Difficulties Questionnaire - Parent version
Time Frame: assessing change from screening, pre, week 4, immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
The scale measure parent-reported adolescent's general mental health, with a higher score indicating worse symptoms.
The study intends to use all three components of the measurement, including 1) the basis of SDQ, which includes 25 items on psychological attributes, 2) impact supplement, measuring functional level.
The follow-up version also includes two additional follow-up questions
|
assessing change from screening, pre, week 4, immediately after the intervention, follow-up 1 month, and at follow-up 6 months]
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motivation Questionnaire
Time Frame: week 2
|
assessments of their motivation to participate in the study and interventions, developed specifically for this study
|
week 2
|
|
Evaluation Questionnaire
Time Frame: immediately after the intervention
|
evaluation assessments of the Modi intervention, developed specifically for this study.
|
immediately after the intervention
|
|
Qualitative interviews
Time Frame: immediately after the intervention
|
Interviews with 15 adolescents from the Modi-group about their experience using the intervention
|
immediately after the intervention
|
|
demographics
Time Frame: pre-intervention
|
gender, age
|
pre-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Smiti Kahlon, PhD, Haukeland University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 714490
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
Clinical Trials on Modi
-
DreaMed DiabetesJaeb Center for Health Research; Abbott Diabetes CareRecruitingType 2 Diabetes (T2D) | Type 1 Diabetes (T1D)United States
-
Scancell LtdRecruitingSquamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Renal Cell Cancer | High Grade Ovarian Serous AdenocarcinomaUnited Kingdom
-
Rabin Medical CenterDreaMed DiabetesRecruitingType 1 Diabetes | Type 2 DiabetesIsrael, Slovenia
-
Madigan Army Medical CenterUnknownLow Back Pain | Myofascial Pain Syndrome Lower BackUnited States